Silver Sulfadiazine Market: By Application & By Geography - Forecast 2016-2021

  • ID: 3973982
  • Report
  • 138 pages
  • IndustryARC
1 of 3
Silver sulfadiazine is an antibacterial drug used for making personal care products. Silver sulfadiazine is listed as the essential medicines by World Health Organization and is widely used as an antibiotic for treating second and third degree burn wounds on the skin. Silver sulfadiazine also helps in preventing the growth of bacteria and yeast on the skin. Silver sulfadiazine is also commonly used to treat urinary tract infections (UTIs). Sulfadiazine, when combined with pyrimethamine, is used for curing the disease Toxoplasmosis. The healing capacity of silver sulfadiazine has been questioned over and again by various researchers and numerous research studies. Despite varied market opinions; silver sulfadiazine remains to be one of the most popular medicines for treatment on burns as it’s is considered to be a powerful medication for burn wounds. Additionally, silver sulfadiazine is used in majority of the hospitals in North America as it is considered the most powerful treatment for burns. Globally increasing incidences of the burn injuries and increasing adoption in developing nations is expected drive the global demand for Silver sulfadiazine during the period of study.

Silver Sulfadiazine Market

Geographically North America dominated silver sulfadiazine market driven by best in the class healthcare infrastructure, advanced facilities, higher awareness, higher technological penetration and higher spending by the citizens towards healthcare expenditure. North America was followed by Europe and Asia-Pacific as second and third largest market for silver sulfadiazine market. Asia Pacific is projected to have fastest growth, owing to rapidly increasing healthcare infrastructure, increased spending, government initiatives and increasing awareness amongst population, and growing medical tourism industry in developing nations such as China, and India in this region.

This report identifies the global silver sulfadiazine market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global silver sulfadiazine market.

This report segments global silver sulfadiazine market on the basis of application and regional market as follows:

Silver Sulfadiazine Market research report is classified on the basis of application. Some of the major applications of silver sulfadiazine covered in this report are as follows: Wound Care, Burn Care, Skin Care, Urinary Tract Infections (UTIs)
This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the silver sulfadiazine market. Some of the major companies’ profiles in detail are as follows:

Johnson & Johnson Limited
3M Company
Baxter International Inc
Monarch Pharmaceuticals
Teva Pharmaceutical Industries Ltd.
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Silver Sulfadiazine Market – Market Overview

2. Executive Summary

3. Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.3. Product Benchmarking
3.4. End User Profiling
3.5. Top 5 Financials Analysis

4. Silver Sulfadiazine Market– Market Forces
4.1. Drivers
4.1.1. Growing cases of burn injuries
4.2. Restraints
4.2.1. Volatile Silver Prices , a major raw material
4.3. Opportunities
4.4. Challenges
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Degree of Competition

5. Silver Sulfadiazine Market– Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors

6. Silver Sulfadiazine Market, By Application
6.1. Wound Care
6.2. Burn Care
6.3. Skin Care
6.4. Urinary Tract Infections (UTIs)
6.5. Personal Care
6.6. Others

7. Silver Sulfadiazine Market, By Geography
7.1. Europe
7.1.1. Germany
7.1.2. France
7.1.3. Italy
7.1.4. Spain
7.1.5. Russia
7.1.6. U.K.
7.1.7. Rest of Europe
7.2. Asia Pacific
7.2.1. China
7.2.2. India
7.2.3. Japan
7.2.4. South Korea
7.2.5. Rest of Asia-Pacific
7.3. North America
7.3.1. U.S.
7.3.2. Canada
7.3.3. Mexico
7.4. Rest of the World (RoW)
7.4.1. Brazil
7.4.2. Rest of RoW

8. Silver Sulfadiazine Market – Market Entropy
8.1. Expansion
8.2. Technological Developments
8.3. Merger & Acquisitions, and Joint Ventures
8.4. Supply- Contract

9. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
9.1. Johnson & Johnson Limited
9.2. 3M Company
9.3. Baxter International Inc
9.4. Monarch Pharmaceuticals
9.5. Teva Pharmaceutical Industries Ltd.
9.6. Pfizer Inc
9.7. BASF SE
9.8. LEK Pharmaceuticals DD
9.9. Mallinckrodt Inc.
9.10. NAPP Chemicals Inc.
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"

10. Appendix
10.1. Abbreviations
10.2. Sources
10.3. Research Methodology
10.4. Bibliography
10.5. Compilation of Expert Insights
10.6. Disclaimer
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll